EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials

医学 随机对照试验 内镜逆行胰胆管造影术 荟萃分析 相对风险 内镜超声 内科学 科克伦图书馆 不利影响 胆道引流 置信区间 胃肠病学 胰腺炎 外科
作者
Eduardo Cerchi Barbosa,Paula Arruda do Espírito Santo,Stefano Baraldo,Angélica Luciana Nau,Gilmara Coelho Meine
出处
期刊:Gastrointestinal Endoscopy [Elsevier BV]
卷期号:100 (3): 395-405.e8 被引量:25
标识
DOI:10.1016/j.gie.2024.04.019
摘要

Background and Aims Increasing evidence support endoscopic ultrasound-guided biliary drainage (EUS-BD) as a potential alternative to endoscopic retrograde cholangiopancreatography-guided biliary drainage (ERCP-BD) in the primary treatment of malignant biliary obstruction (MBO). This systematic review and meta-analysis aimed to compare the efficacy and safety of both techniques as the initial approach for MBO. Methods We searched MEDLINE, Embase, and Cochrane databases for randomized controlled trials (RCTs) comparing both techniques and reporting at least one of the outcomes of interest. The pooled estimates were calculated using the random-effects model and I2 statistics were used to evaluate heterogeneity. Results We included six RCTs (577 patients). There were no significant differences between groups in stent patency (MD 8.18 days; 95% CI -22.55, 38.91), procedure time (MD -6.31 minutes; 95% CI -12.68, 0.06), and survival (MD 4.59 days; 95% CI -34.23, 43.40). Technical success (RR 1.04; 95% CI 0.96, 1.13), clinical success (RR 1.02; 95% CI 0.96, 1.08), overall adverse events (RR 0.58; 95% CI 0.24, 1.43), and cholangitis (RR 1.19; 95% CI 0.39, 3.61) were also similar between groups. However, hospital stay was significantly shorter (MD -1.03 days; 95% CI -1.53, -0.53), and risk of reintervention (RR 0.57; 95% CI 0.37, 0.88), post-procedure pancreatitis (RR 0.15; 95% CI 0.03, 0.66), and tumor in/overgrowth (RR 0.28; 95% CI 0.11, 0.70) were significantly lower with EUS-BD. Conclusions EUS-BD and ERCP-BD had similar efficacy and safety as the initial approach for MBO. However, EUS-BD had a significantly lower risk of reintervention, post-procedure pancreatitis, tumor in/overgrowth, and reduced hospital stay. Increasing evidence support endoscopic ultrasound-guided biliary drainage (EUS-BD) as a potential alternative to endoscopic retrograde cholangiopancreatography-guided biliary drainage (ERCP-BD) in the primary treatment of malignant biliary obstruction (MBO). This systematic review and meta-analysis aimed to compare the efficacy and safety of both techniques as the initial approach for MBO. We searched MEDLINE, Embase, and Cochrane databases for randomized controlled trials (RCTs) comparing both techniques and reporting at least one of the outcomes of interest. The pooled estimates were calculated using the random-effects model and I2 statistics were used to evaluate heterogeneity. We included six RCTs (577 patients). There were no significant differences between groups in stent patency (MD 8.18 days; 95% CI -22.55, 38.91), procedure time (MD -6.31 minutes; 95% CI -12.68, 0.06), and survival (MD 4.59 days; 95% CI -34.23, 43.40). Technical success (RR 1.04; 95% CI 0.96, 1.13), clinical success (RR 1.02; 95% CI 0.96, 1.08), overall adverse events (RR 0.58; 95% CI 0.24, 1.43), and cholangitis (RR 1.19; 95% CI 0.39, 3.61) were also similar between groups. However, hospital stay was significantly shorter (MD -1.03 days; 95% CI -1.53, -0.53), and risk of reintervention (RR 0.57; 95% CI 0.37, 0.88), post-procedure pancreatitis (RR 0.15; 95% CI 0.03, 0.66), and tumor in/overgrowth (RR 0.28; 95% CI 0.11, 0.70) were significantly lower with EUS-BD. EUS-BD and ERCP-BD had similar efficacy and safety as the initial approach for MBO. However, EUS-BD had a significantly lower risk of reintervention, post-procedure pancreatitis, tumor in/overgrowth, and reduced hospital stay.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Maestro_S的应助被Vincent采纳,获得10
3秒前
lichunrong完成签到,获得积分10
3秒前
我不到啊完成签到 ,获得积分10
6秒前
7秒前
朴实无招完成签到,获得积分10
8秒前
随风飘远完成签到 ,获得积分10
12秒前
12秒前
丸子完成签到 ,获得积分10
13秒前
桃子完成签到 ,获得积分10
13秒前
lei.qin完成签到 ,获得积分10
14秒前
cyan完成签到 ,获得积分10
15秒前
LQY完成签到 ,获得积分10
20秒前
态度完成签到 ,获得积分10
21秒前
22秒前
等待念之完成签到,获得积分10
22秒前
赘婿的应助被tianmengkui采纳,获得10
26秒前
27秒前
小呱完成签到 ,获得积分10
28秒前
璇璇完成签到 ,获得积分10
30秒前
拓跋幻枫完成签到,获得积分10
33秒前
33秒前
兰彻完成签到,获得积分10
33秒前
老六完成签到 ,获得积分10
34秒前
勋章完成签到 ,获得积分10
34秒前
唐陌完成签到 ,获得积分10
36秒前
鱼鱼鱼鱼完成签到 ,获得积分10
37秒前
危机的棒棒糖完成签到,获得积分10
39秒前
韭黄完成签到,获得积分10
42秒前
43秒前
tianmengkui完成签到,获得积分10
45秒前
macrossfev完成签到,获得积分10
47秒前
51秒前
韭菜完成签到,获得积分10
51秒前
情怀的应助被tianmengkui采纳,获得10
51秒前
Willwzh完成签到,获得积分10
51秒前
yx完成签到 ,获得积分10
54秒前
56秒前
Sun1c7完成签到,获得积分10
59秒前
新帅完成签到,获得积分10
59秒前
完犊子完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190360
求助须知:如何正确求助?哪些是违规求助? 9577423
关于积分的说明 21852492
捐赠科研通 7788942
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482995